| |
|
|
|
ImmuCell Corporation  
|
|
5.31 -0.19 (-0.03%) |
10-18 11:52 |
|
Open: |
5.41 |
Pre close: |
5.5 |
Target:
|
6.76
|
|
High: |
5.62 |
Low: |
5.3 |
Resistance:
|
5.79
6.76
|
|
Volume: |
5,347 |
Market Cap: |
38M |
Support:
|
5.12
4.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.40
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
5.29  |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
5.93 |
Stochastic Oscillator |
%K(14,3):
|
75.71 |
|
MA(250): |
6.57 |
%D(3): |
77.53 |
|
Average Volume(K) |
3-Month: |
650
|
52-Week |
High:
|
8.44 |
|
10-Days: |
1359 |
Low: |
4.70 |
|
RSI |
RSI(14):
|
48.50 |
Change(%): |
-35.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.300 |
Return on Equity (ttm) |
-6.8 |
Shares Out. (M) |
7.21 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-3.6 |
Shares Float (M) |
5.17 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.25 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-10.1 |
% Held by Institutions |
19.05 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.720 |
Shares Short (K) |
2 |
|
Book Value (p.s.) |
4.110 |
EBITDA (p.s.) |
0.004 |
P/E |
-17.67 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.29 |
|
Profit Margin |
-14.62 |
Operating Cash Flow
(M) |
-0.30 |
P/S |
18640490.00 |
|
Operating Margin |
-16.84 |
Levered Free Cash Flow
(M) |
-0.48 |
P/CF |
-128.34 |
|
|
|
|
|
|
